| Aggregate Evidence Quality . | Grade B . |
|---|---|
| Benefits | Control of BP in children and adolescents with CKD has been shown to decrease CKD progression and lead to resolution of LVH |
| Risks, harm, cost | Cost of ABPM and BP control, both financial and nonfinancial |
| Benefit–harm assessment | Benefits of BP control in patients with CKD outweigh treatment risks |
| Intentional vagueness | Threshold |
| Role of patient preferences | Patients may not want to wear the ambulatory BP monitor repeatedly, which should lead to detailed counseling regarding the benefits of this procedure in CKD |
| Exclusions | None |
| Strength | Strong recommendation |
| Key references | 47,173,203,415,480–483 |
| Aggregate Evidence Quality . | Grade B . |
|---|---|
| Benefits | Control of BP in children and adolescents with CKD has been shown to decrease CKD progression and lead to resolution of LVH |
| Risks, harm, cost | Cost of ABPM and BP control, both financial and nonfinancial |
| Benefit–harm assessment | Benefits of BP control in patients with CKD outweigh treatment risks |
| Intentional vagueness | Threshold |
| Role of patient preferences | Patients may not want to wear the ambulatory BP monitor repeatedly, which should lead to detailed counseling regarding the benefits of this procedure in CKD |
| Exclusions | None |
| Strength | Strong recommendation |
| Key references | 47,173,203,415,480–483 |